NEWS

2012

Month  
October NordMedica Business Development Managers to be present at the CPhI Worldwide Expo 2012 in Madrid, Spain.
  NordMedica International launched Methylthioninium chloride 5mg/ml, Proveblue™ in the Nordic countries. The drug was developed by French Provepharm, and is the only approved methylthionin product that meets the strict European Pharmacopoeia specifications for heavy metals.
August NordMedica International A/S launched Xaluprine® Oral Suspension 20mg/ml (mercaptopurine) in the Nordic and Baltic countries. Xaluprine® developed by Nova Laboratories Ltd. and is the first oral suspension of mercaptopurine for the treatment of ALL.
July NordMedica A/S divested all products to NordMedica International A/S as per July 1st, 2012, except for the product AMEKRIN®/ AMSIDYL®/ AMSIDINE®.
May NordMedica to participate with an exhibition stand for Custodiol (HTK) at The Scandinavian Transplant Society XXVI Congress in Reykjavik, Iceland, from May 9-11, 2012.
April A Seminar on Recent Trends in Cardioplegia open for Thoracic Surgeons and Perfusionists from University Hospitals in Western Sweden was held in Gothenburg.
  Together with our distributor Wasserfall & Massing, Germany, NordMedica arranged an Amsacrine exhibition stand at the EMBT Congress in Geneva from April 1-4, 2012.
  The 4th Nordic Transplant Coordinators Meeting to be held in Copenhagen April 26, 2012.
February A Nordic distribution agreement for Methylthioninium chloride Proveblue, was signed with French ProvePharm S.A.S.
January A promotion agreement for Finland was signed with Sanquin OY, Espoo, Finland.

2011

Month  
October NordMedica will arrange a Cardioplegia seminar open for Thoracic Surgeons from Norwegian University Hospitals in Oslo, Norway, in the beginning of 2012.
  NordMedica Business Development Managers to be present at the CPhI Worldwide Expo 2011 in Frankfurt, Germany.
  NordMedica was for the second year in a row awarded 'Gazelle Growth Company 2011' by the Danish business newspaper, Børsen. Only approx. 4,600 companies has been awarded 'Gazelle Growth Company' for 2 years in a row during the last 16 years.
June A Seminar on Recent Trends in Cardioplegia open for Thoracic Surgeons and Perfusionists from University Hospitals in Denmark and from Lund in Sweden is held in Copenhagen.

Copyright © NordMedica A/S, All Rights Reserved.